A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Stanford University
City of Hope Medical Center
Thomas Jefferson University
ChineseAMS
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Ruijin Hospital
University of Texas Southwestern Medical Center
Ruijin Hospital
Fudan University